There are currently 16 active clinical trials seeking participants for Metastatic Colorectal Cancer research studies. The states with the highest number of trials for Autism participants are California, Texas, Florida and New York.
Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
Recruiting
This study is being done to see if combining liposomal irinotecan with TAS102 and bevacizumab confers clinical benefit for patients with treatment refractory metastatic colorectal cancer.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/31/2023
Locations: University of Wisconsin Carbone Cancer Center, Madison, Wisconsin
Conditions: Metastatic Colorectal Cancer
Pressure-enabled Delivery in Radioembolization (TriNav Study)
Recruiting
The purpose of the study is to determine if the type of catheter used in the mapping procedure prior to radioembolization improves the delivery of radioactivity to tumor(s) in participants with liver cancer. The name of the devices involved in this study are: Pressure Enabled Drug Delivery (PEDD)/TriNav Infusion System Standard 2.4F microcatheter, not otherwise specified
Gender:
All
Ages:
18 years and above
Trial Updated:
09/26/2023
Locations: Massachusetts General Hospital Cancer Center, Boston, Massachusetts +1 locations
Conditions: Liver Cancer, Hepatocellular Carcinoma, Metastatic Colorectal Cancer
Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer
Recruiting
The overall objective of this study is to develop a novel couple-based mindfulness intervention aimed at reducing distress in patients with metastatic colorectal cancer (mCRC) and their partners.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
08/18/2023
Locations: University of Colorado Cancer Center, Aurora, Colorado
Conditions: Metastatic Colorectal Cancer
Dabrafenib + Trametinib + PDR001 In Colorectal Cancer
Recruiting
This research study is studying a combination of drugs as a possible treatment for metastatic colorectal cancer characterized by BRAF V600E mutation. The names of the study drugs involved in this study are: Dabrafenib Trametinib PDR001
Gender:
All
Ages:
18 years and above
Trial Updated:
06/24/2022
Locations: Massachusetts General Hosital Cancer Center, Boston, Massachusetts +1 locations
Conditions: Metastatic Colorectal Cancer